Matrix metalloproteinase-9 and vascular endothelial growth factor: A possible link in adult T-cell leukaemia cell invasion

British Journal of Haematology

Volumn 116, Issue 1, 2002, Pages 94-102

  Maita, Tetsuo ^a   Nakayama, Susumu ^a   Hayashibara, Toshihisa ^a  

^a Nagasaki University   (Japan)

Author keywords

Adult T cell leukaemia; Cell invasion; Matrix metalloproteinase 9; Vascular endothelial growth factor; Zymography

Indexed keywords

GELATINASE B; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL INVASION; CELL SECRETION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; T CELL LEUKEMIA;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKEMIA, T-CELL; LEUKEMIA, T-CELL, ACUTE; LEUKEMIA, T-CELL, CHRONIC; LEUKEMIC INFILTRATION; LYMPHOKINES; LYMPHOMA, T-CELL; MATRIX METALLOPROTEINASE 9; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036162169     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03255.x     Document Type: Article

References (50)

1. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
2. The AP-1 site and MMP gene regulation: What is all the fuss about?
3. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
5. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
6. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
7. Preclinical and clinical studies of MMP inhibitors in cancer
8. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
9. The role of vascular endothelial growth factor in pathological angiogenesis
10. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
11. What is the evidence that tumors are angiogenesis dependent?
12. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
13. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
14. Matrix metalloproteinases in immunity
15. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
16. Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients
17. Vascular endothelial growth factor and cellular chemotaxis, a possible autocrine pathway in adult T-cell leukemia cell invasion
18. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
19. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34 (+) cells and their transmigration through reconstituted basement membrane
20. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
21. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
22. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models
23. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody
24. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor
25. Metalloproteinases and their inhibitors in matrix remodeling
26. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
27. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue
28. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells
29. Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells
30. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer
31. Vascular permeability factor gene expression in normal and neoplastic human ovaries
32. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
33. Localization of messenger RNA for Mr 72,000 and 92, 000 type IV collagenases in human skin cancers by in situ hybridization
34. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma
35. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
36. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
37. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
38. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)
39. Clinical diversity in adult T-cell leukemia-lymphoma
40. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
41. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
42. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
43. Regulation of matrix metalloproteinase expression in tumor invasion
44. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma
45. Established IL-2-dependent double-negative (CD4- CD8-) TCR alphabeta/CD3+ ATL cells: Induction of CD4 expression
46. Features of the cytokines secreted by adult T cell leukemia (ATL) cells
47. Human T-lymphotropic virus type I in Japan
48. Adult T cell leukaemia-lymphoma
49. A proposal for smouldering adult T-cell leukemia - Diversity in clinical pictures of adult T-cell leukemia
50. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease